GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic Steatohepatitis (NASH)

Multi-Biomarker Test Will Provide the Clinical Research Community with a Non-Invasive Tool to Identify and Monitor Patients with NASH and Significant Fibrosis LILLE, France & CAMBRIDGE, Mass. & BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2019-- LabCorp® (NYSE: LH), a leading global life sciences

LabCorp is Scheduled to Present at the 37th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 2, 2019-- LabCorp® (NYSE: LH) today announced it will participate at the 37th Annual J.P. Morgan Healthcare Conference . LabCorp’s presentation is scheduled for Tuesday, January 8, 2019 at 1:30 p.m. (PT) , followed by a question and answer session at 2:00

Covance Xcellerate® Wins Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at 14th Annual Scrip Awards

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 7, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development (Covance) business was awarded Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at the 14th Annual Scrip

Covance Honored with Frost & Sullivan Asia Pacific Award for Fifth Consecutive Year

Awarded CRO 2018 Customer Value Leadership Award BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 6, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development business (Covance) has been awarded the 2018 Frost & Sullivan Asia Pacific CRO Customer

LabCorp Updates Full-Year 2018 Guidance

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 30, 2018-- LabCorp® (or the Company) (NYSE: LH) today updated its full-year 2018 guidance based on current expectations. In the following guidance, all comparisons to financial results in 2017 have been restated as if the Company had adopted the FASB-issued

Be The Match Partners with LabCorp to Help Grow Donor Registry

Enhanced partnership will support equal transplant outcomes for blood cancer and blood disorder patients Be The Match ® and LabCorp have enhanced their long-standing partnership through the launch of an information and enrollment campaign at LabCorp patient service centers with a goal to add a

LabCorp at Walgreens Expands into Southern California

Nine new patient service centers to operate at Walgreens stores in Riverside, California area, with the first four locations now open DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 28, 2018-- Walgreens and LabCorp® (NYSE: LH) today announced the introduction of LabCorp at Walgreens into

LabCorp and Horizon Blue Cross Blue Shield of New Jersey Renew Their Long-Standing Strategic Relationship

LabCorp will remain the exclusive in-network clinical laboratory for the nearly 900,000 Medicaid members of Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ). LabCorp will continue as a preferred provider of laboratory services to all other Horizon BCBSNJ members. NEWARK, N.J.

LabCorp Launches Consumer-Initiated Wellness Test Offering

Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 1, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced the launch of Pixel by LabCorp ℠ , the latest innovation in the